Successful Mesenchymal Stem Cell Trial for Progressive MS from Hadassah [IV vs. IT vs. Placebo]
Mesenchymal stem cells have long been touted as a possible treatment of MS, but this is the first successful randomized trial demonstrating efficacy of both intravenous (IV) and intrathecal (IT) stem cells. This phase II trial with 48 people with progressive MS was run by professor Dimitrios Karussis from the Hadassah MS Centre. Comment or ask questions below! I would be happy to answer! Subscribe on YouTube for more videos every Wednesday! Make video requests in the comments section! Selected Sources: Randomized trial on IT and IV mesenchymal stem cells (The study I am discussing): https://academic.oup.com/brain/advanc... Benefits of mesenchymal stem cells in experimental autoimmune encephalomyelitis; https://pubmed.ncbi.nlm.nih.gov/15905... Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial: https://pubmed.ncbi.nlm.nih.gov/26827... Popular science article from times of Israel: https://www.timesofisrael.com/jerusal... My book "Resilience in the Face of Multiple Sclerosis" on Amazon: https://www.amazon.com/dp/B07WP7H5LK Dr. Brandon Beaber is a board-certified neurologist with subspecialty training in multiple sclerosis and other immunological diseases of the nervous system. He is a partner in the Southern California Permanente Medical Group and practices in Downey, California (South Los Angeles). He has several publications on MS epidemiology and has participated in clinical trials for MS therapeutics. You can follow him on twitter @Brandon_Beaber where he regularly posts about MS news and research. Follow me on twitter: / brandon_beaber Music: INNER GRACE - Copyright 2018 Wilton Vought Source: Really Really Free Music Link: • Video T he video material by Dr. Brandon Beaber is general educational material on health conditions and is not intended to be used by viewers to diagnose or treat any individual's medical condition. Specifically, this material is not a substitute for individualized diagnostic and treatment advice by a qualified medical/health practitioner, licensed in your jurisdiction, who has access to the relevant information available from diagnostic testing, medical interviews, and a physical examination. To the extent that Dr. Beaber endorses any lifestyle change, behavioral intervention, or supplements, the viewer should consult with a qualified healthcare professional to determine the safety and efficacy of the intervention in light of their individualized information.

Mesenchymal Stem Cells for MS Explained by Neurologist

If I Had Multiple Sclerosis, What Would I Do?

How to Focus to Change Your Brain | Huberman Lab Essentials

Episode 458: From the 2026 CMSC Annual Meeting with Dr. Stephen Krieger

I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.

Primary Progressive MS - Ben Thrower, M.D. - May 2017

mRNA COVID shots linked to blood clots? McCullough stuns Senate with explosive claims | 2025 REWIND

Stem Cell Transplant for Multiple Sclerosis (aHSCT)

The NEW 2024 MS Diagnostic Criteria Explained (Game-Changer!)

This New Histamine Treatment Helped 89% of Patients

The Medicine of Frequencies. What did Einstein mean? | Dr. Mitchell Abrams | TEDxTrinityBellwoods

How Immunosuppressive Are Multiple Sclerosis Drugs? Explained by Neurologist

Stem Cells and Next Generation Regenerative Medicine Therapies

Multiple Sclerosis Overview

Can A Stem Cell Transplant Stop Your MS?

Ocrevus vs. Kesimpta for Multiple Sclerosis. Comparison Between the Drugs, Efficacy, Side Effects

NMOSD Master Class | Treating Acute Relapses in NMOSD and MOGAD

Tolebrutinib Effective for Secondary Progressive Multiple Sclerosis (Sanofi Press Release)

We're Probably Going to Cure MS

